June 2014: NCBDDD Strategic Health Initiative Proposal: Prevention of Healthcare Associated VTE (HA-VTE)
Patients who are currently or recently hospitalized, recovering from surgery, or being treated for cancer have an increased risk of developing serious and potentially fatal blood clots in the form of venous thromboembolism (VTE). Each year VTE affects as many as 900,000 Americans leading to approximately 100,000 premature deaths. Associated healthcare costs the United States $10 billion or more each year. Although anyone can develop a blood clot, about 60% of clots are directly related to a recent hospitalization or surgery and most of these do not occur until after discharge.
Effective VTE prevention strategies exist. Unfortunately, prevention is not being implemented consistently across and within healthcare settings. Disseminating and promoting effective evidence-based VTE prevention strategies and providing tools and technology to facilitate and guide uptake and adherence will help providers implement a coordinated health systems-level approach to VTE prevention. Evidence shows that multi-faceted interventions which leverage Health-IT to integrate evidence-based risk assessment, clinical decision support, awareness, and monitoring into patient care will effectively reduce VTE occurrence. CDC’s role as the nation’s prevention and public health agency can help to translate, disseminate, promote and evaluate best practices like these to facilitate widespread implementation. This initiative will help to promote effective prevention strategies and build capacity needed by hospitals and healthcare systems to prevent death and illness from VTE while also providing a much needed means to monitor, evaluate, and report on the outcomes and utility of these efforts. For more information on HA-VTE please visit: http://www.cdc.gov/ncbddd/dvt/features/keyfinding-pba-vte.html.